Inventor

MEDINA JULIO C

US56 patents

⚠️ This page may combine multiple inventors who share the name “MEDINA JULIO C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEDINA JULIO C

AMGEN INC

Asthma and allergic inflammation modulators

CCR4 antagonists

LXR modulators

Triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Intermediates for preparing triazole agonists of the APJ receptor

Methods for preparing triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Intermediates for preparing triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Substituted pyrido[2,3-d]pyrimidines and methods for their use

Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders

Asthma and allergic inflammation modulators

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

Substituted biphenyl GPR40 modulators

Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases

Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders

Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders

Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Compounds that inhibit MCL-1 protein

Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders

Heteroaryl-substituted triazoles as APJ receptor agonists

Triazole furan compounds as agonists of the APJ receptor

Benzo-fused compounds for use in treating metabolic disorders

Pentafluorobenzenesulfonamides and analogs

Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer

TULARIK INC

CXCR3 antagonists

Benzenesulfonamides and benzamides as therapeutic agents

Benzenesulfonamides and benzamides as therapeutic agents

LXR modulators

Hydrazones and analogs as cholesterol lowering agents

Certain polycyclic compounds useful as tubulin-binding agents

ORIC PHARMACEUTICALS INC

Inhibitors of glucocorticoid receptor

Inhibitors of glucocorticoid receptor

Inhibitors of glucocorticoid receptor

Inhibitors of glucocorticoid receptor

Inhibitors of glucocorticoid receptor

Inhibitors of glucocorticoid receptor

AMGEN SF LLC

Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use

Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use

CXCR3 antagonists

Imidazolo-related compounds, compositions and methods for their use

MERCK & CO INC

HIV integrase inhibitors

HIV integrase inhibitors

CHEMOCENTRYX INC

Modulation of CCR4 function

TOTAL ARTS SYNDICATORS INC

Barrier device for contraception and prevention of sexually transmitted diseases

BROWN SEAN P

Spirocyclic GPR40 modulators